SCHEMBL19681584

SCHEMBL19681584

CCCCCCCCC(Cl)CN(CCC(=O)NCCN(C)CCCS(=O)(=O)O)CCN(CCN(CC(Cl)CCCCCCCC)CC(Cl)CCCCCCCC)CCN(CC(Cl)CCCCCCCC)CC(Cl)CCCCCCCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.39
CASP2 P42575 1/20 0.35
NAAA Q02083 1/20 0.34
EPHX2 P34913 1/20 0.34
FAAH O00519 4/20 0.33
POLB P06746 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MMP2 P08253 1/20 0.31
MMP9 P14780 1/20 0.31
MMP8 P22894 1/20 0.31
MMP12 P39900 1/20 0.31
MMP14 P50281 1/20 0.31
ALDH1A1 P00352 1/20 0.31
ICMT O60725 1/20 0.31
ALB P02768 1/20 0.31
TLR2 O60603 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30
CNR1 P21554 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19681638 0.89 DNM1 (0.40) DNM1CASP2NAAAEPHX2FAAH
SCHEMBL25682074 0.85 DNM1 (0.35) DNM1CASP2NAAAEPHX2FAAH
SCHEMBL19681640 0.83 DNM1 (0.35) DNM1CASP2NAAAEPHX2TLR2
SCHEMBL21965331 0.76 DNM1 (0.34) DNM1CASP2NAAAEPHX2FAAH
SCHEMBL25681831 0.74 FAAH (0.36) DNM1CASP2NAAAEPHX2FAAH
SCHEMBL12903714 0.72 CASP2 (0.59) DNM1CASP2NAAAEPHX2FAAH
SCHEMBL12791772 0.72 CASP2 (0.59) DNM1CASP2NAAAEPHX2FAAH
SCHEMBL12903739 0.72 CASP2 (0.59) DNM1CASP2NAAAEPHX2FAAH
SCHEMBL12792311 0.72 CASP2 (0.59) DNM1CASP2NAAAEPHX2FAAH
SCHEMBL12791940 0.72 CASP2 (0.59) DNM1CASP2NAAAEPHX2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170349543-A1 CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349543-A1 CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS ABHD16A, AARS1, CFTR DNM1 700/4885CASP2 2627/4885NAAA 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.